View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Clear Channel Outdoor Holdings, Inc.: Update to credit analysis as CCO...

Our credit view of this issuer reflects its leading market position, constrained by its exposure to cyclical consumer advertising.

 PRESS RELEASE

Appian To Announce Fourth Quarter and Full Year 2024 Financial Results...

Appian To Announce Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 MCLEAN, Va., Jan. 15, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: APPN) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024, before the U.S. financial markets open on Wednesday, February 19, 2025. The company will host a conference call and live webcast to review its financial results and business outlook. Conference Call Details The conference call will begin at 8:30 a.m. Eastern Time. To access the call, please use this . Once registered, p...

 PRESS RELEASE

Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipate...

Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones Continued Focus on Driving Advancement of TN-201 and TN-401 Gene Therapies for Cardiomyopathies Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy Additional Cohort 1 Data to be Reported in 1H25 Building on Promising Initial Data Initial Data from RIDGE™-1 Phase 1b Clinical Trial of TN-401 for PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy Expected in 2H25 SOUTH SAN FRANCISCO, Calif., Jan. 13, ...

 PRESS RELEASE

Atlassian Announces Date for Second Quarter of Fiscal Year 2025 Financ...

TEAM Anywhere/SAN FRANCISCO--(BUSINESS WIRE)-- Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced that it will release financial results for its second quarter of fiscal year 2025 ended December 31, 2024 after market close on Thursday, January 30, 2025. Atlassian will host a conference call to discuss the financial results at 2:00 P.M. Pacific Time. In conjunction with its earnings press release, Atlassian will post a shareholder letter to the Investor Relations section of its website at . Webcast Details When: Thursda...

 PRESS RELEASE

Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase ...

Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy TN-201 Well Tolerated at 3E13 vg/kg Dose AAV9 Capsid Demonstrated Robust Delivery of TN-201 Transgene to Heart Muscle Cells Resulting in Increasing RNA Expression and an Increase in Protein Levels Observed at One Year Circulating Biomarkers and Other Clinical Measures Mostly Remained Stable or Improved from Baseline Tenaya Management to Host a Webcast Conference Call Today at 8:00 a.m. ET SOUTH SAN FRANCISCO, Calif., Dec. 17,...

 PRESS RELEASE

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 ...

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024 Company to host conference call on Tuesday, December 17, at 8:00 a.m. ET SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, will announce initial Cohort 1 data from the MyPEAK-1 Ph...

 PRESS RELEASE

Appian To Participate in Upcoming Investor Conferences

Appian To Participate in Upcoming Investor Conferences MCLEAN, Va., Dec. 05, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: APPN) announced today that management will be presenting and hosting meetings with institutional investors at the following upcoming conferences. Scotiabank Annual Global Technology Conference in San Francisco. The fireside chat is scheduled for Tuesday, December 10th at 2:35pm Pacific Time.Barclays Annual Global Technology Conference in San Francisco. The fireside chat is scheduled for Wednesday, December 11th at 8:05am Pacific Time. It will be webcast live at the following li...

 PRESS RELEASE

BCB Bancorp, Inc. and BCB Community Bank Elect Michael J. Widmer to it...

BCB Bancorp, Inc. and BCB Community Bank Elect Michael J. Widmer to its Boards of Directors BAYONNE, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank” or “BCB”), today announced the election of Michael J. Widmer to the Board of Directors of both BCB Bancorp, Inc. and BCB Community Bank, effective December 4, 2024. Mr. Widmer has over 40 years of banking experience in New Jersey. He most recently worked as a bank consultant for BCB Community Bank where he aided management and staff on a variety of projects incl...

 PRESS RELEASE

Atlassian and Amazon Web Services Announce Strategic Collaboration Agr...

LAS VEGAS--(BUSINESS WIRE)-- At AWS re:Invent today, Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, and Amazon Web Services (AWS), an , Inc. company (NASDAQ: AMZN), announced a multi-year strategic collaboration agreement (SCA) to expedite cloud transformation and deliver advanced AI and security capabilities to enterprise customers. The SCA will help drive the migration of millions of enterprise users from Atlassian’s Data Center business - which generates over $1 billion in annual revenue - to Atlassian Cloud over a multi-year time...

 PRESS RELEASE

Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical ...

Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy TN-401 AAV9-based Gene Therapy Designed to Deliver Fully Functional PKP2 Gene with the Aim of Increasing Protein Levels to Address Underlying Disease RIDGE-1 Currently Enrolling at Six Centers; Observational Natural History and Seroprevalence Study of PKP2-associated ARVC Adults Continues Enrollment at 20 Clinical Sites in the U.S., UK and Europe Initial Clinical Data for RIDGE-1 Anticipated in 2025 SOUTH SAN FRAN...

 PRESS RELEASE

Xos, Inc. Powers Crown Linen Service, Inc.’s Energy Initiatives with B...

Xos, Inc. Powers Crown Linen Service, Inc.’s Energy Initiatives with Battery-Electric Stepvans LOS ANGELES, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Xos, Inc. (NASDAQ: XOS), a leader in the electrification of fleets, is excited to announce a purchase order from Crown Linen Service, Inc., a leading provider of linen and uniform rental services. Crown Linen has ordered two fully electric 22' stepvans, reflecting its commitment to sustainability and reducing its environmental impact. “We are thrilled to partner with XOS, Inc. in our journey towards a greener future,” said Plato Spilios, Co-Presi...

 PRESS RELEASE

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rul...

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that it granted stock options to purchase an aggregate of 12,000 shares of Tenaya common stock to two new non-executive employees in connection with the commencement of their employment. The stock options have an exercise...

 PRESS RELEASE

Xos, Inc. delivers strong unit delivery and promising gross profit per...

Xos, Inc. delivers strong unit delivery and promising gross profit performance in the third quarter of 2024 Delivered fifth consecutive quarter of positive gross margins LOS ANGELES, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Xos, Inc. (NASDAQ: XOS) (“Xos” or the “Company”), a leading electric truck manufacturer and fleet services provider, today reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights: Generated revenues of $15.8 million, up from $15.5 million last quarter and down from $16.7 million in the third quarter of 2023Delivered...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: November 9, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Appian Announces Third Quarter 2024 Financial Results

Appian Announces Third Quarter 2024 Financial Results Third quarter cloud subscription revenue increased 22% year-over-year to $94.1 million MCLEAN, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced financial results for the third quarter ended September 30, 2024. “Appian continues to grow even as we become more efficient. Growth remains our top priority. We now project positive adjusted EBITDA for the full year 2024,” said Matt Calkins, CEO & Founder. Third Quarter 2024 Financial Highlights: Revenue: Cloud subscription revenue was $94.1 million, up 22% com...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: November 6, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and P...

Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update Data Safety and Monitoring Board Endorsed Dose Escalation and Broadening of Inclusion Criteria in the MyPEAKTM-1 Phase 1b/2 Trial of TN-201 Gene Therapy Initial TN-201 Data from Cohort 1 of MyPEAK-1 to be Reported in December 2024 SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart d...

 PRESS RELEASE

Xos, Inc. Announces Third Quarter 2024 Earnings Release Date and Confe...

Xos, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call LOS ANGELES, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Xos, Inc. (NASDAQ: XOS), a leading electric truck manufacturer and fleet services provider, announced it is scheduling the release of its third quarter 2024 operating results for Wednesday, November 13, 2024 after the close of the U.S. financial markets. Management will host a conference call to discuss these financial results at 4:30 p.m. Eastern Daylight Time / 1:30 p.m. Pacific Daylight Time that same day. Conference Call and Webcast Details D...

 PRESS RELEASE

Atlassian Announces First Quarter Fiscal Year 2025 Results

TEAM, Anywhere/SAN FRANCISCO--(BUSINESS WIRE)-- Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced financial results for its first quarter ended September 30, 2024. A shareholder letter was posted on Atlassian’s Work Life blog at and in the Investor Relations section of Atlassian’s website at . First Quarter Fiscal Year 2025 Earnings Results “Through the power of our R&D engine, we’re not just marketing AI, we’re shipping it. I’m thrilled our team was able to launch Rovo, our latest product built for the AI era, into gen...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch